Two patients with rituximab associated low gammaglobulin levels and relapsed covid-19 infections treated with convalescent plasma

Patients with haematological malignancies are considered to be a risk group for developing severe Coronavirus disease (Covid-19). Because of the limitations of therapeutic options, the development of new treatment strategies is mandatory, such as convalescent plasma (CP). Herein we report the use of...

Descripción completa

Detalles Bibliográficos
Autores principales: Ormazabal Vélez, Irati, Induráin Bermejo, Juan, Espinoza Pérez, José, Imaz Aguayo, Laura, Delgado Ruiz, Marina, García-Erce, José Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894088/
https://www.ncbi.nlm.nih.gov/pubmed/33637467
http://dx.doi.org/10.1016/j.transci.2021.103104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894088/
https://www.ncbi.nlm.nih.gov/pubmed/33637467
http://dx.doi.org/10.1016/j.transci.2021.103104

Ejemplares similares